 Phuong Le
Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 12 | 2025 | 606 | 1.960 |
Why?
| | Neoplastic Stem Cells | 6 | 2020 | 399 | 1.010 |
Why?
| | Carcinoma, Squamous Cell | 8 | 2019 | 683 | 0.970 |
Why?
| | Papillomaviridae | 3 | 2025 | 125 | 0.960 |
Why?
| | Wnt Signaling Pathway | 2 | 2018 | 192 | 0.910 |
Why?
| | Cell Culture Techniques | 1 | 2025 | 363 | 0.800 |
Why?
| | Papillomavirus Infections | 2 | 2025 | 325 | 0.730 |
Why?
| | Cell Communication | 1 | 2018 | 315 | 0.520 |
Why?
| | Tumor Microenvironment | 2 | 2020 | 674 | 0.480 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2014 | 41 | 0.440 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2014 | 220 | 0.390 |
Why?
| | Recombinant Fusion Proteins | 1 | 2014 | 665 | 0.370 |
Why?
| | Xenograft Model Antitumor Assays | 8 | 2020 | 872 | 0.310 |
Why?
| | Cell Line, Tumor | 8 | 2025 | 3412 | 0.270 |
Why?
| | Antineoplastic Agents | 3 | 2016 | 2129 | 0.270 |
Why?
| | Cancer-Associated Fibroblasts | 1 | 2025 | 20 | 0.240 |
Why?
| | Coculture Techniques | 1 | 2025 | 239 | 0.230 |
Why?
| | Hedgehog Proteins | 3 | 2015 | 195 | 0.220 |
Why?
| | Mice, Nude | 4 | 2018 | 698 | 0.210 |
Why?
| | Hyaluronan Receptors | 2 | 2020 | 102 | 0.200 |
Why?
| | B7-H1 Antigen | 1 | 2023 | 217 | 0.180 |
Why?
| | Flow Cytometry | 1 | 2025 | 1178 | 0.180 |
Why?
| | Cetuximab | 3 | 2015 | 98 | 0.170 |
Why?
| | SOXB1 Transcription Factors | 2 | 2020 | 62 | 0.160 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2020 | 47 | 0.160 |
Why?
| | Tumor Cells, Cultured | 2 | 2018 | 955 | 0.160 |
Why?
| | Mice | 12 | 2023 | 17787 | 0.160 |
Why?
| | Neoplasms | 1 | 2014 | 2671 | 0.160 |
Why?
| | Stem Cell Niche | 1 | 2019 | 54 | 0.150 |
Why?
| | Animals | 15 | 2023 | 36940 | 0.150 |
Why?
| | Mouth Neoplasms | 1 | 2019 | 120 | 0.150 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2018 | 52 | 0.140 |
Why?
| | Peptides, Cyclic | 1 | 2020 | 259 | 0.140 |
Why?
| | Salivary Gland Neoplasms | 1 | 2018 | 41 | 0.140 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2013 | 804 | 0.140 |
Why?
| | Neoplasm Invasiveness | 1 | 2018 | 510 | 0.130 |
Why?
| | Veratrum Alkaloids | 2 | 2014 | 19 | 0.130 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2016 | 26 | 0.130 |
Why?
| | Cell Proliferation | 3 | 2019 | 2475 | 0.130 |
Why?
| | Disease Models, Animal | 4 | 2020 | 4295 | 0.130 |
Why?
| | ErbB Receptors | 3 | 2016 | 614 | 0.120 |
Why?
| | Immunotherapy | 1 | 2020 | 641 | 0.120 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 1692 | 0.120 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 406 | 0.120 |
Why?
| | Replication Protein A | 1 | 2014 | 13 | 0.110 |
Why?
| | DNA-Activated Protein Kinase | 1 | 2014 | 17 | 0.110 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2014 | 44 | 0.110 |
Why?
| | Stromal Cells | 1 | 2014 | 112 | 0.110 |
Why?
| | Homologous Recombination | 1 | 2014 | 28 | 0.110 |
Why?
| | Radiation Tolerance | 1 | 2014 | 96 | 0.110 |
Why?
| | Melanoma | 1 | 2020 | 760 | 0.100 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2020 | 1079 | 0.100 |
Why?
| | Immunophenotyping | 3 | 2019 | 318 | 0.100 |
Why?
| | Humans | 17 | 2025 | 137585 | 0.100 |
Why?
| | Leukemia, Radiation-Induced | 1 | 2012 | 4 | 0.100 |
Why?
| | Sulfones | 1 | 2013 | 110 | 0.100 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2018 | 622 | 0.100 |
Why?
| | Microsatellite Instability | 1 | 2012 | 42 | 0.100 |
Why?
| | Glycine | 1 | 2013 | 176 | 0.100 |
Why?
| | Gamma Rays | 1 | 2012 | 57 | 0.100 |
Why?
| | DNA Replication | 1 | 2014 | 238 | 0.100 |
Why?
| | Proto-Oncogene Proteins | 2 | 2013 | 648 | 0.100 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 1396 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1276 | 0.090 |
Why?
| | Mice, Inbred NOD | 2 | 2023 | 601 | 0.080 |
Why?
| | Trans-Activators | 1 | 2012 | 398 | 0.080 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2020 | 366 | 0.080 |
Why?
| | Apoptosis | 1 | 2018 | 2553 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2014 | 712 | 0.080 |
Why?
| | Immunohistochemistry | 3 | 2019 | 1738 | 0.070 |
Why?
| | RNA, Messenger | 1 | 2016 | 2833 | 0.070 |
Why?
| | Signal Transduction | 4 | 2016 | 5079 | 0.070 |
Why?
| | Dose-Response Relationship, Radiation | 2 | 2020 | 141 | 0.060 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2012 | 630 | 0.060 |
Why?
| | Mutation | 4 | 2018 | 3958 | 0.050 |
Why?
| | Cell Cycle Proteins | 2 | 2020 | 617 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2016 | 412 | 0.050 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2023 | 249 | 0.050 |
Why?
| | Zinc Finger E-box-Binding Homeobox 1 | 1 | 2020 | 24 | 0.040 |
Why?
| | Feedback, Physiological | 1 | 2020 | 77 | 0.040 |
Why?
| | Peptide Chain Elongation, Translational | 1 | 2020 | 18 | 0.040 |
Why?
| | Radiotherapy Dosage | 1 | 2020 | 268 | 0.040 |
Why?
| | Heterografts | 1 | 2019 | 138 | 0.040 |
Why?
| | Hyaluronic Acid | 1 | 2020 | 225 | 0.040 |
Why?
| | Chemoradiotherapy | 1 | 2020 | 225 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 194 | 0.040 |
Why?
| | DNA Repair | 1 | 2020 | 231 | 0.040 |
Why?
| | Biomarkers | 2 | 2019 | 4149 | 0.030 |
Why?
| | Monocytes | 1 | 2020 | 563 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 430 | 0.030 |
Why?
| | DNA Damage | 1 | 2020 | 420 | 0.030 |
Why?
| | Retinal Dehydrogenase | 1 | 2016 | 29 | 0.030 |
Why?
| | Cell Cycle | 1 | 2020 | 601 | 0.030 |
Why?
| | Carcinogenesis | 1 | 2018 | 217 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2016 | 257 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2016 | 100 | 0.030 |
Why?
| | Spheroids, Cellular | 1 | 2016 | 76 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2019 | 1389 | 0.030 |
Why?
| | Maximum Tolerated Dose | 1 | 2015 | 199 | 0.030 |
Why?
| | Cadherins | 1 | 2016 | 206 | 0.030 |
Why?
| | Zinc Finger Protein GLI1 | 1 | 2014 | 25 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 1060 | 0.030 |
Why?
| | Cell Division | 1 | 2016 | 794 | 0.030 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 35 | 0.030 |
Why?
| | Checkpoint Kinase 1 | 1 | 2014 | 30 | 0.030 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2016 | 327 | 0.030 |
Why?
| | Cricetulus | 1 | 2014 | 109 | 0.030 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 66 | 0.030 |
Why?
| | CHO Cells | 1 | 2014 | 161 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 686 | 0.030 |
Why?
| | Female | 5 | 2020 | 73304 | 0.030 |
Why?
| | Cricetinae | 1 | 2014 | 289 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2016 | 452 | 0.030 |
Why?
| | Serine | 1 | 2014 | 141 | 0.030 |
Why?
| | Antigens, CD | 1 | 2016 | 521 | 0.030 |
Why?
| | Receptor, Notch2 | 1 | 2013 | 15 | 0.030 |
Why?
| | Receptor Cross-Talk | 1 | 2013 | 21 | 0.030 |
Why?
| | Gonanes | 1 | 2013 | 27 | 0.030 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2013 | 95 | 0.030 |
Why?
| | Alphapapillomavirus | 1 | 2013 | 39 | 0.030 |
Why?
| | Linear Energy Transfer | 1 | 2012 | 3 | 0.020 |
Why?
| | Cesium Radioisotopes | 1 | 2012 | 3 | 0.020 |
Why?
| | Chromatids | 1 | 2012 | 9 | 0.020 |
Why?
| | Receptor, Notch1 | 1 | 2013 | 64 | 0.020 |
Why?
| | Mice, Inbred CBA | 1 | 2012 | 54 | 0.020 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2014 | 209 | 0.020 |
Why?
| | Gene Silencing | 1 | 2013 | 195 | 0.020 |
Why?
| | Protein Kinases | 1 | 2014 | 319 | 0.020 |
Why?
| | Chromosome Aberrations | 1 | 2012 | 156 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 843 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2012 | 317 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2018 | 3015 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1774 | 0.020 |
Why?
| | Gene Expression | 1 | 2015 | 1502 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1226 | 0.020 |
Why?
| | Male | 4 | 2020 | 67762 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1710 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2757 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 971 | 0.020 |
Why?
| | Iron | 1 | 2012 | 313 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1759 | 0.020 |
Why?
| | Single-Cell Analysis | 1 | 2012 | 313 | 0.020 |
Why?
| | Computational Biology | 1 | 2013 | 644 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2013 | 801 | 0.020 |
Why?
| | Transcription Factors | 1 | 2014 | 1719 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 33479 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2015 | 10811 | 0.010 |
Why?
| | Aged | 1 | 2019 | 23961 | 0.010 |
Why?
|
|
Le's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|